Domestic Data Foreign Data PMS Pivotal dose-response IIa PK / PD Personal Perspective on Bridging Domestic Data Foreign Data PMS Pivotal dose-response IIa PK / PD
“Bridge” is one of many bridges in the development of a new drug “Bridge” is one of many bridges in the development of a new drug. It is not bigger, but rather smaller. Non-Clinical Clinical I IIa IIb III
PK parameter Clinical endpoint Dose PD parameter
Analysis of Dissimilarity Dose PK parameter Clinical endpoint PD parameter Clinical endpoint Clinical endpoint PD PK = . . Dose PD PK Dose
Bridging in Baseball Batting Average Japan U.S. Ichiro Ichiro Shinjo 0.400 Ichiro 0.380 0.360 Ichiro 0.340 0.320 Japan U.S. 0.300 0.280 Shinjo Shinjo 0.260 0.240 0.220 0.200